NASDAQ:DOMH Dominari (DOMH) Stock Price, News & Analysis $3.10 0.00 (0.00%) Closing price 06/5/2026 04:00 PM EasternExtended Trading$3.07 -0.03 (-0.97%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Dominari Stock (NASDAQ:DOMH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dominari alerts:Sign Up Key Stats Today's Range$3.00▼$3.2850-Day Range$2.75▼$3.9252-Week Range$2.68▼$8.40Volume280,107 shsAverage Volume266,336 shsMarket Capitalization$70.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York. Read More Dominari Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreDOMH MarketRank™: Dominari scored higher than 6% of companies evaluated by MarketBeat, and ranked 846th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingDominari has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageDominari has received no research coverage in the past 90 days.Read more about Dominari's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Dominari is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dominari is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDominari has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Dominari's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.22% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 1.86, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently increased by 9.67%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDominari does not currently pay a dividend.Dividend GrowthDominari does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Dominari this week, compared to 1 article on an average week.Search Interest12 people have searched for DOMH on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows2 people have added Dominari to their MarketBeat watchlist in the last 30 days. Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Dominari insiders have not sold or bought any company stock.Percentage Held by Insiders55.30% of the stock of Dominari is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dominari's insider trading history. Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOMH Stock News HeadlinesHead to Head Contrast: Dominari (NASDAQ:DOMH) and Integrated BioPharma (OTCMKTS:INBP)June 6 at 4:05 AM | americanbankingnews.comDominari Holdings Restructures Series B Warrants for CapitalMay 27, 2026 | tipranks.com$36 million a day says something big is comingInstitutional capital is flowing into one thesis at a rate of $36 million per day - $25,000 every single minute. Morgan Stanley puts the addressable market at $5 trillion, and the smart money is already positioned. Pentagon-funded research from Rensselaer Polytechnic Institute identified a precise tipping point: once roughly 10% of a population adopts a new idea, the rest of the system flips fast. That threshold was just crossed. Porter Stansberry, with nearly 30 years in the markets, says this opportunity is bigger than dot-com, crypto, and the 2023 AI rally combined.June 8 at 1:00 AM | Porter & Company (Ad)Dominari Holdings Congratulates Cerebras Systems on "Blockbuster" Initial Public OfferingMay 15, 2026 | prnewswire.comDominari Holdings Issues Shareholder LetterMay 13, 2026 | prnewswire.comDominari Q1 Revenue Increases by 395% Over Q1 2025May 13, 2026 | prnewswire.comDominari Holdings Announces Record Date for Cash DividendMay 4, 2026 | prnewswire.comDominari 2025 Revenue Surges 487% in 2025, Balance Sheet Strengthens SignificantlyMarch 31, 2026 | prnewswire.comSee More Headlines DOMH Stock Analysis - Frequently Asked Questions How have DOMH shares performed this year? Dominari's stock was trading at $4.95 at the beginning of the year. Since then, DOMH stock has decreased by 37.4% and is now trading at $3.10. How were Dominari's earnings last quarter? Dominari Holdings Inc. (NASDAQ:DOMH) issued its earnings results on Wednesday, May, 13th. The company reported ($2.11) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $1.94. The company earned $35.81 million during the quarter, compared to analysts' expectations of $35.81 million. Dominari had a negative net margin of 31.37% and a negative trailing twelve-month return on equity of 206.20%. Who are Dominari's major shareholders? Top institutional shareholders of Dominari include Renaissance Technologies LLC (0.59%) and PFG Investments LLC (0.06%). Insiders that own company stock include Christopher Franklin Devall and Kyle Michael Wool. View institutional ownership trends. How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dominari own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), Kroger (KR), KraneShares CSI China Internet ETF (KWEB) and MSP Recovery (LIFW). Company Calendar Last Earnings5/13/2026Record date for 5/29 Dividend5/15/2026Ex-Dividend for 5/29 Dividend5/15/2026Dividend Payable5/29/2026Today6/08/2026Next Earnings (Estimated)8/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 DOMH's financial health is in the Yellow zone, according to TradeSmith. DOMH has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryBiotechnology Current SymbolNASDAQ:DOMH Previous SymbolNASDAQ:DOMH CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($4.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$22.43 million Net Margins-31.37% Pretax Margin-16.67% Return on Equity-206.20% Return on Assets-155.26% Debt Debt-to-Equity RatioN/A Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$123.10 million Price / Sales0.57 Cash FlowN/A Price / Cash FlowN/A Book Value$4.28 per share Price / Book0.72Miscellaneous Outstanding Shares22,610,000Free Float10,108,000Market Cap$70.09 million OptionableNot Optionable Beta0.80 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free Report This page (NASDAQ:DOMH) was last updated on 6/8/2026 by MarketBeat.com Staff. From Our PartnersThe "hidden" half of the SpaceX IPOMost investors are focused on the SpaceX IPO - but the bigger opportunity may lie elsewhere. On Feb. 2, Elon M...Weiss Ratings | SponsoredThis ‘Starburst’ Could Be Bigger Than the SpaceX IPOMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredWhy I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)The media's calling it "the biggest IPO in Wall Street history." But I'm not buying it. Institutions got into ...Decentralized Masters | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX billions need somewhere to go — this is itThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...Crypto 101 Media | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dominari With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
